Published in J Eukaryot Microbiol on January 01, 2003
Pneumocystis pneumonia. N Engl J Med (2004) 5.86
Pneumocystis pneumonia in patients treated with rituximab. Chest (2013) 3.48
Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest (2004) 3.44
An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. Am J Respir Crit Care Med (2011) 2.70
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results. Am J Respir Crit Care Med (2009) 2.63
Current insights into the biology and pathogenesis of Pneumocystis pneumonia. Nat Rev Microbiol (2007) 2.50
Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol (2005) 1.88
Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med (2002) 1.81
Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest (2003) 1.61
Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am J Respir Cell Mol Biol (2005) 1.45
Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair. Am J Physiol Cell Physiol (2014) 1.44
Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome. Respiration (2005) 1.39
Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis (2010) 1.38
Familial idiopathic pulmonary fibrosis: clinical features and outcome. Chest (2005) 1.34
Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J Biol Chem (2002) 1.33
Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest (2005) 1.27
Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J Biol Chem (2003) 1.21
An Official ATS Workshop Summary: Recent advances and future directions in pneumocystis pneumonia (PCP). Proc Am Thorac Soc (2006) 1.16
Pneumocystis carinii cell wall biosynthesis kinase gene CBK1 is an environmentally responsive gene that complements cell wall defects of cbk-deficient yeast. Infect Immun (2004) 1.15
Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J Immunol (2006) 1.13
Fitness of cell-mediated immunity independent of repertoire diversity. J Immunol (2007) 1.11
Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Respir Res (2010) 1.07
Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer. J Thorac Oncol (2007) 1.01
Lung epithelial cells and extracellular matrix components induce expression of Pneumocystis carinii STE20, a gene complementing the mating and pseudohyphal growth defects of STE20 mutant yeast. Infect Immun (2003) 0.98
Pneumocystis carinii exhibits a conserved meiotic control pathway. Infect Immun (2007) 0.97
Redefining the clinical spectrum of chronic pulmonary histoplasmosis: a retrospective case series of 46 patients. Medicine (Baltimore) (2007) 0.97
Advances in the biology, pathogenesis and identification of Pneumocystis pneumonia. Curr Opin Pulm Med (2008) 0.97
Pneumocystis pneumonia: current concepts in pathogenesis, diagnosis, and treatment. Clin Chest Med (2009) 0.95
A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn Microbiol Infect Dis (2006) 0.95
Temozolomide-associated organizing pneumonitis. Mayo Clin Proc (2007) 0.92
Drug-induced lung disease: a pragmatic classification incorporating HRCT appearances. Semin Respir Crit Care Med (2003) 0.92
Macrophage internalization of fungal beta-glucans is not necessary for initiation of related inflammatory responses. Infect Immun (2005) 0.91
Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun (2003) 0.91
Pneumocystis cell wall beta-glucan stimulates calcium-dependent signaling of IL-8 secretion by human airway epithelial cells. Respir Res (2010) 0.90
Pneumocystis PCINT1, a molecule with integrin-like features that mediates organism adhesion to fibronectin. Mol Microbiol (2007) 0.90
Other HIV-associated pneumonias. Clin Chest Med (2013) 0.87
Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. J Thorac Oncol (2014) 0.86
Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease. Chest (2012) 0.86
Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia (2012) 0.86
Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum (2005) 0.86
Idiopathic pulmonary fibrosis: is it a familial disease? Curr Opin Pulm Med (2006) 0.86
Characterization of the PcCdc42 small G protein from Pneumocystis carinii, which interacts with the PcSte20 life cycle regulatory kinase. Am J Physiol Lung Cell Mol Physiol (2009) 0.85
Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. Respir Med (2008) 0.84
Diffuse pulmonary lymphangiomatosis. Can Respir J (2013) 0.84
Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis. Chest (2004) 0.84
Pneumocystis carinii STE11, an HMG-box protein, is phosphorylated by the mitogen activated protein kinase PCM. Gene (2003) 0.84
Characterization of a lanosterol 14 alpha-demethylase from Pneumocystis carinii. Am J Respir Cell Mol Biol (2003) 0.84
Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev Res (Phila) (2011) 0.84
Glycosphingolipids mediate pneumocystis cell wall β-glucan activation of the IL-23/IL-17 axis in human dendritic cells. Am J Respir Cell Mol Biol (2012) 0.84
Characterization of PCEng2, a {beta}-1,3-endoglucanase homolog in Pneumocystis carinii with activity in cell wall regulation. Am J Respir Cell Mol Biol (2009) 0.83
Pneumocystis carinii expresses an active Rtt109 histone acetyltransferase. Am J Respir Cell Mol Biol (2010) 0.83
The Pneumocystis Ace2 transcription factor regulates cell wall-remodeling genes and organism virulence. J Biol Chem (2013) 0.82
Surfactant protein D enhances Pneumocystis infection in immune-suppressed mice. Am J Physiol Lung Cell Mol Physiol (2005) 0.82
Drug-associated acute lung injury: a population-based cohort study. Chest (2012) 0.82
The Pneumocystis meiotic PCRan1p kinase exhibits unique temperature-regulated activity. Am J Respir Cell Mol Biol (2009) 0.81
The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia. Semin Respir Infect (2003) 0.81
Primary alveolar epithelial cell surface membrane microdomain function is required for Pneumocystis β-glucan-induced inflammatory responses. Innate Immun (2012) 0.81
Subtractive hybridization analysis of Pneumocystis carinii gene activation induced by interaction with lung epithelial cells and matrix. Chest (2002) 0.80
Evidence for a melanin cell wall component in Pneumocystis carinii. Infect Immun (2003) 0.80
Characterization of lymphocyte populations in nonspecific interstitial pneumonia. Respir Res (2005) 0.80
Characterization of the Pneumocystis carinii histone acetyltransferase chaperone proteins PcAsf1 and PcVps75. Infect Immun (2013) 0.79
Pneumocystis carinii interactions with lung epithelial cells and matrix proteins induce expression and activity of the PcSte20 kinase with subsequent phosphorylation of the downstream cell wall biosynthesis kinase PcCbk1. Infect Immun (2011) 0.78
Pneumonia. Treatment and diagnosis. Ann Am Thorac Soc (2014) 0.78
Pneumocystis carinii BCK1 complements the Saccharomyces cerevisiae cell wall integrity pathway. J Eukaryot Microbiol (2003) 0.78
Pneumocystis nomenclature. Clin Infect Dis (2006) 0.78
Pneumocystis melanins confer enhanced organism viability. Eukaryot Cell (2006) 0.78
Chitinases in Pneumocystis carinii pneumonia. Med Microbiol Immunol (2012) 0.78
Older adults with chronic lung disease report less limitation compared with younger adults with similar lung function impairment. Ann Am Thorac Soc (2015) 0.77
Pneumocystis carinii BCK1 functions in a mitogen-activated protein kinase cascade regulating fungal cell-wall assembly. FEBS Lett (2003) 0.77
Characterization of a novel ADAM protease expressed by Pneumocystis carinii. Infect Immun (2009) 0.76
Response. Chest (2013) 0.75
Stress in the ER (endoplasmic reticulum): a matter of life and death for epithelial cells. Am J Respir Crit Care Med (2008) 0.75
Response. Chest (2014) 0.75
Clinical approach and management for selected fungal infections in pulmonary and critical care patients. Chest (2014) 0.75
Pulmonary Langerhans' cell histiocytosis. Semin Respir Crit Care Med (2002) 0.75
Melanin-like pigments in Pneumocystis carinii. J Eukaryot Microbiol (2003) 0.75